Detailed price information for Praxis Precision Medicines Inc (PRAX-Q) from The Globe and Mail including charting and trades.
Children referred to a first seizure clinic often see a neurologist epilepsy specialist within 1 week for timely diagnosis ...
The Neurology Advisor Team spoke with Shilpa Reddy, MD, MMHC at AES 2025 in Atlanta, Georgia. Neurology Advisor: “Can you describe your work in neuromodulation?” ...
Praxis Precision Medicines Inc. (NASDAQ:PRAX) is one of the best biotech stocks to buy according to Wall Street analysts. On ...
Discusses Latest Phase III Updates for Azetukalner in Epilepsy and Commercial Launch Preparation December 10, 2025 ...
The newly formed Stop ECT Coalition, representing hundreds of thousands of individuals, has launched a nationwide campaign ...
Detailed price information for Praxis Precision Medicines Inc (PRAX-Q) from The Globe and Mail including charting and trades.
A sweeping review of more than 2,500 studies reveals that despite booming public enthusiasm, cannabis has strong scientific ...
2d
Bombshell cannabis study reveals hidden risks of medical pot that may actually outweigh any benefits
The review also found that daily use of medical cannabis — especially inhaled or high-potency products — may increase the ...
A proposed CMS rule hints that some Medicare plans could cover certain legal CBD products, bringing cannabinoids a step ...
The AAN’s first-ever functional seizure guideline targets stigma and unnecessary treatment, offering clearer diagnostic steps ...
Emerging clinical and autopsy evidence points to late-onset epilepsy as a potentially distinct, neurodegeneration-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback